NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Zeta Global Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2025. SO WHAT: If you purchased Zeta securities during ...

文章核心观点 - 罗森律师事务所提醒在2024年5月10日至2024年10月17日期间购买Humacyte, Inc. (NASDAQ: HUMA)证券的投资者注意2025年1月17日的首席原告截止日期 如果投资者在此期间购买了Humacyte证券，可能有权获得赔偿，无需支付任何费用或成本 投资者可以通过罗森律师事务所加入集体诉讼 [1][2] 行动指南 - 投资者可以通过访问https://rosenlegal.com/submit-form/?case_id=31305或致电Phillip Kim, Esq. (866-767-3653)或发送电子邮件至case@rosenlegal.com加入Humacyte集体诉讼 已经有一项集体诉讼被提起 如果希望担任首席原告，必须在2025年1月17日之前向法院提出动议 首席原告是代表其他集体成员指导诉讼的代表方 [2] 罗森律师事务所的优势 - 罗森律师事务所鼓励投资者选择具有成功领导角色记录的合格律师 许多发出通知的律师事务所没有类似的经验、资源或任何有意义的同行认可 许多这些律师事务所实际上并不诉讼证券集体诉讼，而只是中间人，将客户或与实际诉讼案件的律师事务所合作 罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼 罗森律师事务所在当时实现了对中国公司最大的证券集体诉讼和解 罗森律师事务所在2017年ISS证券集体诉讼服务排名中名列第一 自2013年以来，该律师事务所每年都排名前四，并已为投资者追回了数亿美元 仅在2019年，该律师事务所就为投资者追回了超过4.38亿美元 2020年，创始合伙人Laurence Rosen被law360评为原告酒吧的泰坦 该律师事务所的许多律师已被Lawdragon和Super Lawyers认可 [3] 案件详情 - 根据诉讼，在集体诉讼期间，被告做出了虚假和/或误导性的陈述，和/或未能披露以下内容：(1) Humacyte的Durham, North Carolina设施未能遵守良好的制造实践，包括质量保证和微生物测试 (2) 由于Humacyte纠正这些缺陷，FDA对生物制品许可证申请(BLA)的审查将被推迟 (3) 因此，FDA批准无细胞组织工程血管(ATEV)用于血管创伤存在重大风险 (4) 因此，被告关于Humacyte的业务、运营和前景的积极陈述在实质上是误导性的，或缺乏合理依据 当真实细节进入市场时，诉讼声称投资者遭受了损失 [4]

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TMC the metals company Inc. (NASDAQ: TMC) between May 12, 2023 and March 25, 2024, both dates inclusive (the “Class Period”), of the important January 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased TMC securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

文章核心观点 - 罗森律师事务所宣布代表在2024年1月25日至2024年10月28日期间购买了Xerox Holdings Corporation（纳斯达克代码：XRX）证券的投资者提起集体诉讼 [1] 诉讼详情 - 诉讼指控Xerox在集体诉讼期间发布了虚假和/或误导性的声明，未能披露以下事实： - 在大幅裁员后，Xerox的销售团队进行了重组，包括新的区域分配和账户覆盖 [5] - 这导致Xerox的销售团队生产力受到干扰 [5] - 因此，Xerox的旧产品销售率下降 [5] - 清理旧产品的困难将推迟关键产品的发布 [5] - 因此，Xerox的销售和收入可能会下降 [5] - 这些因素导致Xerox关于其业务、运营和前景的正面声明具有误导性或缺乏合理依据 [5] 投资者行动 - 在集体诉讼期间购买Xerox证券的投资者可能有权获得赔偿，无需支付任何费用或成本 [2] - 投资者可以通过访问https://rosenlegal.com/submit-form/?case_id=31433或联系Phillip Kim律师（电话：866-767-3653，邮箱：case@rosenlegal.com）加入Xerox集体诉讼 [3][6] - 投资者可以选择自己的律师，也可以选择不采取任何行动，作为缺席的集体成员 [7] 罗森律师事务所介绍 - 罗森律师事务所鼓励投资者选择具有成功领导经验的合格律师 [4] - 罗森律师事务所在证券集体诉讼和股东衍生诉讼方面有丰富的经验，并在2017年ISS证券集体诉讼服务排名中名列第一 [4] - 罗森律师事务所的律师多次被Lawdragon和Super Lawyers认可 [4]

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 17, 2025. SO WHAT: If you purchased Humacyte securities during the Class P ...

NEW YORK, Nov. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Visa Inc. (NYSE: V) between November 16, 2023, and September 23, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2025 in the securities class action first filed by the Firm. SO WHAT: If you purc ...

核心事件 - Rosen Law Firm提醒在2022年11月11日至2024年9月30日期间购买Flux Power Holdings Inc (NASDAQ: FLUX)证券的投资者2024年12月31日是证券集体诉讼的主要原告截止日期 [1] 投资者权益 - 若在上述期间购买了Flux Power证券可能有权通过胜诉酬金安排获得赔偿无需支付任何自掏腰包的费用或成本 [2] 参与诉讼方式 - 可通过https://rosenlegal.com/submit - form/?case_id = 28783或致电Phillip Kim免费电话866 - 767 - 3653或发邮件至case@rosenlegal.com获取集体诉讼信息若想担任主要原告必须在2024年12月31日前向法院提出申请 [3][6] Rosen Law Firm优势 - 鼓励投资者选择有成功领导经验的合格律师事务所很多发通知的公司没有可比经验资源或同行认可Rosen Law Firm在全球代表投资者专注于证券集体诉讼和股东派生诉讼曾达成针对中国公司的最大规模证券集体诉讼和解2017年被ISS Securities Class Action Services评为证券集体诉讼和解数量第一自2013年以来每年排名前4仅2019年就为投资者追回超过4.38亿美元2020年创始合伙人Laurence Rosen被law360评为原告律师界的泰坦许多律师得到Lawdragon和Super Lawyers认可 [4] 案件详情 - 诉讼称被告在整个期间作出重大虚假和/或误导性陈述和/或未披露Flux Power从2022年11月10日至今的财务报表存在高估存货毛利润流动资产和总资产低估销售成本和净亏损需要重述之前的财务报表低估内部控制弱点或声称有足够内部控制实际没有被告关于业务运营和前景的陈述在所有相关时间都是重大虚假和误导性的和/或缺乏合理依据当真实细节进入市场投资者遭受损失 [5] 其他事项 - 尚未有集体诉讼被认证在认证之前除非自己聘请否则没有律师代表可自行选择律师也可保持缺席不做任何事投资者分享潜在未来赔偿的能力不取决于是否担任主要原告 [7]

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iLearningEngines, Inc. (NASDAQ: AILE) between April 22, 2024 and August 28, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased iLearningEngines securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iris Energy Limited (NASDAQ: IREN) between June 20, 2023 and July 11, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased Iris Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of ordinary shares of ASML Holding N.V. (NASDAQ: ASML) between January 24, 2024 and October 15, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025. SO WHAT: If you purchased ASML ordinary shares durin ...